MX2021009570A - Compuestos biciclicos sustituidos como moduladores del receptor de farnesoide x. - Google Patents
Compuestos biciclicos sustituidos como moduladores del receptor de farnesoide x.Info
- Publication number
- MX2021009570A MX2021009570A MX2021009570A MX2021009570A MX2021009570A MX 2021009570 A MX2021009570 A MX 2021009570A MX 2021009570 A MX2021009570 A MX 2021009570A MX 2021009570 A MX2021009570 A MX 2021009570A MX 2021009570 A MX2021009570 A MX 2021009570A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- farnesoid
- receptor modulators
- substituted bicyclic
- bicyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806402P | 2019-02-15 | 2019-02-15 | |
| PCT/US2020/018210 WO2020168148A1 (fr) | 2019-02-15 | 2020-02-14 | Composés bicycliques substitués utilisés en tant que modulateurs du récepteur farnésoïde x |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021009570A true MX2021009570A (es) | 2021-09-08 |
Family
ID=69811924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021009570A MX2021009570A (es) | 2019-02-15 | 2020-02-14 | Compuestos biciclicos sustituidos como moduladores del receptor de farnesoide x. |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU2020221370A1 (fr) |
| BR (1) | BR112021015963A2 (fr) |
| CA (1) | CA3129533A1 (fr) |
| EA (1) | EA202192263A1 (fr) |
| MX (1) | MX2021009570A (fr) |
| SG (1) | SG11202108796YA (fr) |
| WO (1) | WO2020168148A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023510274A (ja) | 2020-01-15 | 2023-03-13 | アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） | Ｄ型肝炎ウイルスによる感染を処置するためのｆｘｒアゴニストの使用 |
| AU2022209084A1 (en) | 2021-01-14 | 2023-08-10 | Centre Leon Bérard | Synergistic effect of a fxr agonist and ifn for the treatment of hbv infection |
| CA3213217A1 (fr) | 2021-04-28 | 2022-11-03 | Raphael Darteil | Potentialisation forte d'effets d'agonistes de tlr3 a l'aide d'agonistes de fxr en tant que traitement combine |
| CN115340536A (zh) * | 2021-05-13 | 2022-11-15 | 华东理工大学 | 含1,2,4-恶二唑的酰胺类化合物及其盐、制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7319104B2 (en) | 2002-03-01 | 2008-01-15 | Smithkline Beecham Corporation | hPPARs activators |
| US7189712B2 (en) | 2002-10-10 | 2007-03-13 | Smithkline Beecham Corporation | 1,3-Oxazole compounds for the treatment of cancer |
| CN103720688A (zh) | 2005-04-08 | 2014-04-16 | Ptc医疗公司 | 用于无义突变抑制治疗的口服活性1,2,4-噁二唑组合物 |
| US20120065196A1 (en) | 2006-07-21 | 2012-03-15 | Shuji Kitamura | Amide compounds |
| EP2917203B1 (fr) | 2012-11-02 | 2019-04-03 | Dana-Farber Cancer Institute, Inc. | Procédé d'identification d'inhibiteurs de myc |
| CN106661056B (zh) | 2014-06-19 | 2019-07-05 | 百时美施贵宝公司 | 作为酪蛋白激酶1δ/ε抑制剂的咪唑并哒嗪衍生物 |
| US10208573B2 (en) | 2014-09-10 | 2019-02-19 | Halliburton Energy Services, Inc. | Perforating gun with integrated retaining system |
| CA3055990A1 (fr) * | 2017-03-15 | 2018-09-20 | Metacrine, Inc. | Agonistes du recepteur farnesoide x et leurs utilisations |
| CN110637015B (zh) * | 2017-03-15 | 2024-04-02 | 奥加诺沃公司 | 法尼醇x受体激动剂及其用途 |
-
2020
- 2020-02-14 SG SG11202108796YA patent/SG11202108796YA/en unknown
- 2020-02-14 MX MX2021009570A patent/MX2021009570A/es unknown
- 2020-02-14 EA EA202192263A patent/EA202192263A1/ru unknown
- 2020-02-14 CA CA3129533A patent/CA3129533A1/fr active Pending
- 2020-02-14 AU AU2020221370A patent/AU2020221370A1/en not_active Abandoned
- 2020-02-14 BR BR112021015963-0A patent/BR112021015963A2/pt not_active Application Discontinuation
- 2020-02-14 WO PCT/US2020/018210 patent/WO2020168148A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020168148A1 (fr) | 2020-08-20 |
| CA3129533A1 (fr) | 2020-08-20 |
| EA202192263A1 (ru) | 2022-01-27 |
| SG11202108796YA (en) | 2021-09-29 |
| BR112021015963A2 (pt) | 2021-10-05 |
| AU2020221370A1 (en) | 2021-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021009570A (es) | Compuestos biciclicos sustituidos como moduladores del receptor de farnesoide x. | |
| MX2021009694A (es) | Compuestos biciclicos sustituidos como moduladores del receptor farnesoide x. | |
| EA202091063A1 (ru) | Мостиковые бициклические соединения в качестве модуляторов фарнезоидного х-рецептора | |
| EA201991127A1 (ru) | ЦИКЛОБУТАН- И АЗЕТИДИНСОДЕРЖАЩИЕ МОНО- И СПИРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ИНТЕГРИНА αV | |
| EA202091084A1 (ru) | Алкеновые спироциклические соединения как модуляторы фарнезоидных x-рецепторов | |
| EA202091101A1 (ru) | Спироциклические соединения в качестве модуляторов фарнезоидного x-рецептора | |
| EA201991122A1 (ru) | 3-ЗАМЕЩЕННЫЕ ПРОПАНОВЫЕ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ИНТЕГРИНА αV | |
| ZA202101960B (en) | Protein tyrosine phosphatase inhibitors | |
| MX2019005243A (es) | Derivados de indazol como antagonistas de integrina alfa v. | |
| CR20210501A (es) | Inhibidores de la proteína tirosina fosfatasa | |
| MX2019005233A (es) | Pirrolamidas como inhibidores de la integrina alfa v. | |
| MX2022001784A (es) | Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos. | |
| MX2019005234A (es) | Amidas y aminas de azol como inhibidores de integrina alfa v. | |
| EA201390969A1 (ru) | Модуляторы глюкагонового рецептора | |
| MX2019011844A (es) | Proceso para la preparación de derivados de ácidos biliares de sulfonil carbamato. | |
| MX2021003706A (es) | Tratamiento del temblor esencial usando (r)-2-(4-isopropilfenil)-n -(1-(5-(2,2,2- trifluoroetoxi)piridin-2-il)etil)acetamida. | |
| MX2021009424A (es) | Compuestos de amida sustituida utiles como moduladores del receptor de farnesoide x. | |
| ECSP19072975A (es) | Derivados pirazol[1,5-a]pirimidina sustituidos con alicíclicos farmacológicamente activos | |
| MX2021009564A (es) | Compuestos de amida sustituida utiles como moduladores del receptor de farnesoide x. | |
| EA201891038A1 (ru) | Антагонисты мускаринового рецептора 4 и способы их применения | |
| EA202190801A1 (ru) | Ингибиторы протеинтирозинфосфатазы | |
| MX2022005912A (es) | Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria. |